Cardinal Health, Inc. operates as an integrated healthcare services and products company, serving hospitals, healthcare systems, pharmacies, and patients across multiple regions including the U.S., Canada, Europe, and Asia. The company has two main segments: Pharmaceutical, which accounts for approximately 70% of revenue, focuses on the distribution of branded and generic pharmaceuticals, specialty products, and related services; and Medical, which comprises around 30% of revenue, providing medical and surgical products, supply chain services, and procedure kits. Revenue is generated through product sales and service contracts with healthcare providers and manufacturers. Factors supporting endurance include a diverse product portfolio and established relationships within the healthcare sector, while potential limitations may arise from regulatory changes and pricing pressures in the healthcare market.
—
Cardinal Health, Inc. operates as an integrated healthcare services and products company, serving hospitals, healthcare systems, pharmacies, and patients across multiple regions including the U.S., Canada, Europe, and Asia. The company has two main segments: Pharmaceutical, which accounts for approximately 70% of revenue, focuses on the distribution of branded and generic pharmaceuticals, specialty products, and related services; and Medical, which comprises around 30% of revenue, providing medical and surgical products, supply chain services, and procedure kits. Revenue is generated through product sales and service contracts with healthcare providers and manufacturers. Factors supporting endurance include a diverse product portfolio and established relationships within the healthcare sector, while potential limitations may arise from regulatory changes and pricing pressures in the healthcare market.
—
Daily adjusted close
Cardinal Health, Inc. operates as an integrated healthcare services and products company, serving hospitals, healthcare systems, pharmacies, and patients across multiple regions including the U.S., Canada, Europe, and Asia. The company has two main segments: Pharmaceutical, which accounts for approximately 70% of revenue, focuses on the distribution of branded and generic pharmaceuticals, specialty products, and related services; and Medical, which comprises around 30% of revenue, providing medical and surgical products, supply chain services, and procedure kits. Revenue is generated through product sales and service contracts with healthcare providers and manufacturers. Factors supporting endurance include a diverse product portfolio and established relationships within the healthcare sector, while potential limitations may arise from regulatory changes and pricing pressures in the healthcare market.